Among pediatric CNS neoplasms, MET gene fusions have to this day exclusively been reported in the context of infantile high-grade gliomas, while a distinctive enrichment in hemispheric tumors has been observed and recurrent MET gene fusions as PTPRZ1::MET have been reported [6, 9, 19, 20]. The gene discussed is MET; the disease is central nervous system cancer.